Which of the following is a risk factor for prostate cancer?

A. Increasing high-density lipoprotein (HDL) cholesterol levels is a physiological outcome or goal, but it is not a direct behavioral modification in itself. While exercise and dietary changes can raise HDL, the measurement is a biological marker rather than the intervention. The actual modification would be the lifestyle changes that lead to improved lipid profiles.

B. Achieving and maintaining a body mass index (BMI) within the normal range is a direct behavioral modification through caloric management and physical activity. Weight reduction directly lowers systemic inflammation, improves insulin sensitivity, and reduces the workload on the myocardium. This proactive lifestyle change specifically addresses the modifiable risk of obesity to prevent atherosclerotic progression.

C. Reducing systolic blood pressure to below 120 mmHg is a clinical target that often requires pharmacological intervention or lifestyle changes. While blood pressure is a modifiable risk factor, the target value is the result of the modification rather than the action taken. The individual modifies their risk by reducing sodium intake or increasing aerobic exercise.

D. Normalizing fasting blood glucose levels is a metabolic objective intended to reduce the risk of diabetes-related vascular damage. Like blood pressure, the blood glucose level is a metric that reflects the success of lifestyle or medical interventions. The modification involves the dietary and exercise choices that prevent the development of hyperglycemia and insulin resistance.

A. Direct extension from the bladder to the kidneys: This describes the progression of an existing infection rather than the primary mechanism of entry into the system. While vesicoureteral reflux allows pathogens to move from the bladder to the renal pelvis, the bacteria must first enter the lower tract. This downward-to-upward movement within the system is a secondary stage of infection.

B. Hematogenous spread from distant infections: This pathway involves bacteria traveling through the bloodstream to seed the kidneys, which is a rare cause of urinary infections in healthy adults. It usually occurs in immunocompromised patients or those with specific systemic bacteremia, such as Staphylococcus aureus. It does not represent the common route for typical community-acquired infections.

C. Ascending migration from the urethra: Most urinary tract infections occur when fecal flora, particularly Escherichia coli, colonize the periurethral area and migrate upward into the bladder. The short length of the female urethra specifically facilitates this mechanical movement of pathogens into the sterile urinary environment. This is the most frequent pathophysiological route for both cystitis and subsequent pyelonephritis.

D. Lymphatic spread from adjacent structures: While theoretically possible, the transport of bacteria through lymphatic vessels from the bowel or other pelvic organs to the urinary tract is clinically negligible. It does not account for the vast majority of diagnosed clinical cases. Most pathogens identified in urine cultures are those that thrive through mucosal adherence and ascending motility.